Skip to content

Safety and Efficacy of Intracranial Thrombosis Aspiration Catheter for Recanalization Therapy in Acute Ischemic Stroke within 24 Hours Time Window -— A Prospective, Multicenter, Blind Endpoint, Single Arm Clinical Trial

Safety and Efficacy of Intracranial Thrombosis Aspiration Catheter for Recanalization Therapy in Acute Ischemic Stroke within 24 Hours Time Window — A Prospective, Multicenter, Blind Endpoint, Single Arm Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022855
Enrollment
Unknown
Registered
2019-04-28
Start date
2019-05-13
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke caused by anterior circulation intracranial large vessel occlusion

Interventions

Experimental:Mechanical thrombectomy with Aspiration Catheter

Sponsors

Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged = 18 years. 2. Symptoms and signs in accordance with anterior circulation ischemia and large vessel occlusion (ICA, MCA-M1 or M2) confirmed by DSA. 3. Pre-operation modified Rankin Scale(mRS)0-1. 4. NIHSS score = 6 points at time of randomization. 5.The patients should receive endovascular treatment within 24 hours of estimated time of large vessel occlusion (LVO) onset. If the treatment could happen within 6 hours, the patient should have an ASPECTS = 6 points on non-enhanced CT. If the treatment could happen 6-24 hours after LVO, the patient should meet the condition of CTP/CTA-SI or PWI/DWI mismatch, and have an ASPECTS = 6 points on CTA-SI or DWI. 6. It is recommended for patients without intravenous thrombolysis contraindications to have intravenous thrombolysis with tPA (IVT), if IVT could be started within 4.5 hours of estimated time of LVO. For AIS patients with an unknown time of onset, IVT guided by a mismatch between DWI and FLAIR in the region of ischemia is also recommended. 7. Written informed consent obtained from patient or patient's legally authorized representative.

Exclusion criteria

Exclusion criteria: 1.Acute posterior circulation cerebral infarction comfirmed by CT or MRI. 2.Any type of cerebral hemorrhage (only microbleeds are allowed) on neuroimaging. 3.Large (more than one-third of the MCA) regions of clear hypodensity on the baseline CT scan or ASPECTS 22.2 mmol/L. 15.Baseline blood pressure > 185/110 mmHg, or aggressive treatment (intravenous medication) necessary to reduce blood pressure to these limits. 16.Pregnant or lactating or positive pregnancy test on admission. 17.Dementia or psychiatric disease that would confound the neurological or functional evaluations. 18.Life expectancy less than 1 year. 19.Current participation in another drug or device research. 20.Patients who are referred to the clinical trial center from other hospital, and are not suitable to re-imaging at the center. 21.Other special situations which the researchers believe to be not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Instant recanalization rate (mTICI 2b-3) of target vessel after the procedure;

Secondary

MeasureTime frame
Proportion of functional independence (mRS 0-2) at 90 days;Ordinal shift analysis of mRS at 90 days;Instant recanalization rate (mTICI 2b-3) after the first aspiration;Instant recanalization rate (mTICI 2b-3) after the last aspiration;The proportion of rescue therapy;Procedure time (femoral artery puncture to recanalization);Change in NIHSS score at 24±2 hours;Change in NIHSS score at 7±1 days or discharge;mTICI grading of target vessel revealed by CTA or MRA at 22-36 hours;The extent of anterior circulation infarction at 22-36 hours, as measured by ASPECTS on CT or MRI;

Countries

China

Contacts

Public ContactZhongrong Miao

Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University

zhongrongm@163.com+86 13601243293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026